ITMI932540A1 - Composizione farmaceutica - Google Patents

Composizione farmaceutica

Info

Publication number
ITMI932540A1
ITMI932540A1 IT93MI002540A ITMI932540A ITMI932540A1 IT MI932540 A1 ITMI932540 A1 IT MI932540A1 IT 93MI002540 A IT93MI002540 A IT 93MI002540A IT MI932540 A ITMI932540 A IT MI932540A IT MI932540 A1 ITMI932540 A1 IT MI932540A1
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
pharmaceutical compositions
therapeutic agent
compositions containing
relates
Prior art date
Application number
IT93MI002540A
Other languages
English (en)
Inventor
Tiziana Crolla
Franco Francese
Massimo Maneschi
Diego Oldani
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Publication of ITMI932540A0 publication Critical patent/ITMI932540A0/it
Priority to ITMI932540A priority Critical patent/IT1274241B/it
Priority to CN94194885A priority patent/CN1145586A/zh
Priority to PCT/EP1994/003903 priority patent/WO1995015155A1/en
Priority to AU12198/95A priority patent/AU693144B2/en
Priority to JP7515376A priority patent/JPH09505818A/ja
Priority to EP95903281A priority patent/EP0804168A1/en
Priority to NZ277238A priority patent/NZ277238A/en
Priority to CA002177721A priority patent/CA2177721A1/en
Priority to ZA949567A priority patent/ZA949567B/xx
Publication of ITMI932540A1 publication Critical patent/ITMI932540A1/it
Application granted granted Critical
Publication of IT1274241B publication Critical patent/IT1274241B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6943—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a pill, a tablet, a lozenge or a capsule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invenzione si riferisce a complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono.
ITMI932540A 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono IT1274241B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI932540A IT1274241B (it) 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
JP7515376A JPH09505818A (ja) 1993-12-03 1994-11-24 薬／ポリマー複合体含有の風味をマスクした組成物
PCT/EP1994/003903 WO1995015155A1 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex
AU12198/95A AU693144B2 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex
CN94194885A CN1145586A (zh) 1993-12-03 1994-11-24 含药物/聚合物复合物的味掩蔽组合物
EP95903281A EP0804168A1 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex
NZ277238A NZ277238A (en) 1993-12-03 1994-11-24 Taste masked composition containing paroxetine complexed with a polymer
CA002177721A CA2177721A1 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex
ZA949567A ZA949567B (en) 1993-12-03 1994-12-01 Chewable taste masked complexes containing pharmaceuticals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932540A IT1274241B (it) 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
ITMI932540A0 ITMI932540A0 (it) 1993-12-03
ITMI932540A1 true ITMI932540A1 (it) 1995-06-03
IT1274241B IT1274241B (it) 1997-07-15

Family

ID=11367288

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932540A IT1274241B (it) 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono

Country Status (9)

Country Link
EP (1) EP0804168A1 (it)
JP (1) JPH09505818A (it)
CN (1) CN1145586A (it)
AU (1) AU693144B2 (it)
CA (1) CA2177721A1 (it)
IT (1) IT1274241B (it)
NZ (1) NZ277238A (it)
WO (1) WO1995015155A1 (it)
ZA (1) ZA949567B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU748804B2 (en) * 1995-07-20 2002-06-13 Smithkline Beecham Plc Paroxetine controlled release compositions
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US5965555A (en) * 1996-06-07 1999-10-12 Hoechst Aktiengesellschaft Xanthine compounds having terminally animated alkynol side chains
DE19631084A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EE03970B1 (et) 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
AU3810100A (en) 1999-03-12 2000-10-04 Basf Aktiengesellschaft Stable pharmaceutical application form for paroxetin anhydrate
GB0119467D0 (en) * 2001-08-09 2001-10-03 Smithkline Beecham Plc Novel compound
ES2261726T3 (es) * 2001-08-09 2006-11-16 Smithkline Beecham Plc Composicion que comprende paroxetina y una sal glicirricinato farmaceuticamente aceptable.
PT2802311T (pt) * 2011-10-25 2019-03-19 Expermed S A Composição farmacêutica sublingual contendo um agente anti-histamínico e método para a sua preparação

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ217326A (en) * 1985-08-26 1990-02-26 Searle & Co A porous, active drug-polymer matrix having masked taste properties, wherein the active drug contains amine or amido groups

Also Published As

Publication number Publication date
EP0804168A1 (en) 1997-11-05
WO1995015155A1 (en) 1995-06-08
JPH09505818A (ja) 1997-06-10
NZ277238A (en) 1998-04-27
ITMI932540A0 (it) 1993-12-03
AU1219895A (en) 1995-06-19
CN1145586A (zh) 1997-03-19
AU693144B2 (en) 1998-06-25
IT1274241B (it) 1997-07-15
CA2177721A1 (en) 1995-06-08
ZA949567B (en) 1995-10-10

Similar Documents

Publication Publication Date Title
ITMI932540A1 (it) Composizione farmaceutica
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
CA2225808A1 (en) Silver-based pharmaceutical compositions
DE3484573D1 (de) Durchdringende topische pharmazeutische zusammensetzungen mit gehalt an n-(2-hydroxyethyl)-pyrrolidon.
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
FI904444A0 (fi) Aktiva limkompositioner.
ITFI930083A1 (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
IL102337A0 (en) Pyrrolpyrazines,their manufacture and pharmaceutical compositions containing them
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
BR1100143A (pt) Composto, e, composição farmacêutica.
IL108624A0 (en) Pseudopeptides, their preparation and pharmaceutical compositions containing them
CA2047802A1 (en) Pharmaceutical compositions
ITMI932543A1 (it) Composizione farmaceutica
FR2695297B1 (fr) Composition d'agent désinfectant.
LV10579A (lv) Farmaceitiska kompozicija
DE69420453D1 (de) Schweisszusammensetzung
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
ATE201996T1 (de) Hirudin enthaltende pharmazeutische zusammensetzungen
IL93719A0 (en) (5(6)(benzisoxa-benzisothia-or indazol-3-yl)-1h-benzimidazol-2-yl)carbamates,their preparation and pharmaceutical compositions containing them
ITMI911147A0 (it) Composto ad attivita' terapeutica,sua preparazione e composizioni farmaceutiche che lo contengono
IL110833A0 (en) Naphthoxazines, their preparation and pharmaceutical compositions containing them
DE68907609D1 (de) Arzneimittelzusammensetzung.
ES2090170T3 (es) Agente de recubrimiento espermicida.
MY117887A (en) Phenyl-substituted 1, 4 - dihydropyridines

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19981231